Device type · MJP
Lens, Intraocular, Toric Optics
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MJP
Ophthalmic
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
1,814
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Lens, Intraocular, Toric Optics
- Product code
- MJP
- Device class
- Class III
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
- FDA record
- Classification database entry for MJP
Latest FDA decisions
P910056-S027 · Decided Jun 8, 2018 · 221 days after receipt · Panel Track
Device type: LENS, INTRAOCULAR, TORIC OPTICS (MJP) · Ophthalmology
Reports received
1,814
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
1,067
59% of reports
Injury reports
747
41% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 36 | 56 | 0 | 0 |
| Jan 24 | 22 | 36 | 0 | 0 |
| Feb 24 | 36 | 51 | 0 | 0 |
| Mar 24 | 39 | 51 | 0 | 0 |
| Apr 24 | 36 | 50 | 0 | 0 |
| May 24 | 31 | 62 | 0 | 0 |
| Jun 24 | 41 | 48 | 0 | 0 |
| Jul 24 | 39 | 61 | 0 | 0 |
| Aug 24 | 39 | 46 | 0 | 0 |
| Sep 24 | 41 | 60 | 0 | 0 |
| Oct 24 | 55 | 66 | 0 | 0 |
| Nov 24 | 41 | 61 | 0 | 0 |
| Dec 24 | 72 | 71 | 0 | 0 |
| Jan 25 | 65 | 45 | 0 | 0 |
| Feb 25 | 58 | 54 | 0 | 0 |
| Mar 25 | 78 | 41 | 0 | 0 |
| Apr 25 | 283 | 67 | 0 | 0 |
| May 25 | 74 | 74 | 0 | 0 |
| Jun 25 | 55 | 52 | 0 | 0 |
| Jul 25 | 65 | 60 | 0 | 0 |
| Aug 25 | 80 | 55 | 0 | 0 |
| Sep 25 | 73 | 49 | 0 | 0 |
| Oct 25 | 76 | 76 | 0 | 0 |
| Nov 25 | 85 | 41 | 0 | 0 |
| Dec 25 | 81 | 75 | 0 | 0 |
| Jan 26 | 65 | 43 | 0 | 0 |
| Feb 26 | 71 | 63 | 0 | 0 |
| Mar 26 | 87 | 40 | 0 | 0 |
| Apr 26 | 123 | 79 | 0 | 0 |
| May 26 | 95 | 57 | 0 | 0 |
| Jun 26 | 83 | 71 | 0 | 0 |
| Jul 26 | 98 | 64 | 0 | 0 |
| Aug 26 | 96 | 68 | 0 | 0 |
| Sep 26 | 85 | 77 | 0 | 0 |
| Oct 26 | 98 | 69 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem595
- Break219
- Device Difficult to Setup or Prepare154
- Scratched Material150
- Failure to Deliver138
- Material Twisted/Bent108
- Device Dislodged or Dislocated84
- Product Quality Problem64
- Failure to Advance62
- Material Split, Cut or Torn57
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions575
- Insufficient Information567
- Blurred Vision330
- Visual Impairment280
- Visual Disturbances202
- Eye Injury27
- Halo22
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available18
- Diplopia/Double Vision18
- Capsular Bag Tear17
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- TECNIS Toric II OptiBlue IOL Models ZCWOpen, Classified
Johnson & Johnson Surgical Vision, Inc.
Z-0735-2024 · Started Dec 12, 2023 · Posted by FDA Jan 16, 2024
Reason given: Due to intraocular lens containing an angle out of specification (OOS). The cylinder axis marks do not meet product specifications for the allowable angle between Low Power Meridian (LPM) and toric cylinder axis marks.
Cause as FDA categorized it: Under Investigation by firm
Johnson & Johnson Surgical Vision Inc
Z-0028-2022 · Started Aug 6, 2021
Reason given: Nonconforming product was distributed in error. Product was nonconforming due endotoxin levels higher than both the Firm's internal endotoxin specification limit and the FDA recommended endotoxin specification limit. Product was released in error based on the results of additional testing performed during the...
Cause as FDA categorized it: Process control
Johnson & Johnson Surgical Vision Inc
Z-1163-2021 · Started Jan 27, 2021
Reason given: Due to the release of nonconforming Intraocular Lenses (IOLs).
Cause as FDA categorized it: Process change control
Z-0519-2021 · Started Nov 7, 2020
Reason given: Product may be missing toric axis marks.
Cause as FDA categorized it: Process change control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.